Patents/Assignees

Agonox, Inc.

2 patents in portfolio

US12358968utility2025
Utilization of CD39 and CD103 for Identification of Human Tumor Reactive T Cells for Treatment of Cancer
0 cites
US11572541utility2023
Utilization of CD39 and CD103 for Identification of Human Tumor Reactive T Cells for Treatment of Cancer
0 cites